237 related articles for article (PubMed ID: 15037339)
41. Empirical validation of competing definitions of schizophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis.
Cuesta MJ; Peralta V; Zarzuela A
Schizophr Res; 2007 Sep; 95(1-3):39-47. PubMed ID: 17651943
[TBL] [Abstract][Full Text] [Related]
42. Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms.
Barch DM; Carter CS; MacDonald AW; Braver TS; Cohen JD
J Abnorm Psychol; 2003 Feb; 112(1):132-43. PubMed ID: 12653421
[TBL] [Abstract][Full Text] [Related]
43. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
[TBL] [Abstract][Full Text] [Related]
44. Changes in cognitive function associated with syndrome changes on two five-factor models of the Positive and Negative Syndrome Scale.
Jerrell JM; Hrisko S
Hum Psychopharmacol; 2012 Nov; 27(6):566-76. PubMed ID: 23817989
[TBL] [Abstract][Full Text] [Related]
45. Neuropsychological substrates and everyday functioning implications of prospective memory impairment in schizophrenia.
Twamley EW; Woods SP; Zurhellen CH; Vertinski M; Narvaez JM; Mausbach BT; Patterson TL; Jeste DV
Schizophr Res; 2008 Nov; 106(1):42-9. PubMed ID: 18055178
[TBL] [Abstract][Full Text] [Related]
46. Galantamine added to antipsychotic treatment in chronic schizophrenia: cognitive improvement?
Norén U; Björner A; Sonesson O; Eriksson L
Schizophr Res; 2006 Jul; 85(1-3):302-4. PubMed ID: 16675200
[No Abstract] [Full Text] [Related]
47. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
Minzenberg MJ; Poole JH; Benton C; Vinogradov S
Am J Psychiatry; 2004 Jan; 161(1):116-24. PubMed ID: 14702259
[TBL] [Abstract][Full Text] [Related]
48. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
49. Impaired executive performance in healthy siblings of schizophrenia patients in a population-based study.
Kuha A; Tuulio-Henriksson A; Eerola M; Perälä J; Suvisaari J; Partonen T; Lönnqvist J
Schizophr Res; 2007 May; 92(1-3):142-50. PubMed ID: 17344027
[TBL] [Abstract][Full Text] [Related]
50. Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients.
Subotnik KL; Nuechterlein KH; Green MF; Horan WP; Nienow TM; Ventura J; Nguyen AT
Schizophr Res; 2006 Jul; 85(1-3):84-95. PubMed ID: 16624529
[TBL] [Abstract][Full Text] [Related]
51. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
[TBL] [Abstract][Full Text] [Related]
52. Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?
Brüne M; Abdel-Hamid M; Lehmkämper C; Sonntag C
Schizophr Res; 2007 May; 92(1-3):151-9. PubMed ID: 17346931
[TBL] [Abstract][Full Text] [Related]
53. Patterns and clinical correlates of neuropsychologic deficits in patients with schizophrenia.
Liu SK; Hsieh MH; Huang TJ; Liu CM; Liu CC; Hua MS; Chen WJ; Hwu HG
J Formos Med Assoc; 2006 Dec; 105(12):978-91. PubMed ID: 17185240
[TBL] [Abstract][Full Text] [Related]
54. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome.
Keefe RS; Poe M; Walker TM; Harvey PD
J Clin Exp Neuropsychol; 2006 Feb; 28(2):260-9. PubMed ID: 16484097
[TBL] [Abstract][Full Text] [Related]
55. Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits.
Roth RM; Flashman LA; Saykin AJ; McAllister TW; Vidaver R
Am J Psychiatry; 2004 Jan; 161(1):157-9. PubMed ID: 14702265
[TBL] [Abstract][Full Text] [Related]
56. Are deficits in executive sub-processes simply reflecting more general cognitive decline in schizophrenia?
Donohoe G; Clarke S; Morris D; Nangle JM; Schwaiger S; Gill M; Corvin A; Robertson IH
Schizophr Res; 2006 Jul; 85(1-3):168-73. PubMed ID: 16716568
[TBL] [Abstract][Full Text] [Related]
57. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
[TBL] [Abstract][Full Text] [Related]
58. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia.
Hoff AL; Sakuma M; Razi K; Heydebrand G; Csernansky JG; DeLisi LE
Am J Psychiatry; 2000 Nov; 157(11):1824-8. PubMed ID: 11058480
[TBL] [Abstract][Full Text] [Related]
59. Dissociation of cognitive from affective components of theory of mind in schizophrenia.
Shamay-Tsoory SG; Shur S; Barcai-Goodman L; Medlovich S; Harari H; Levkovitz Y
Psychiatry Res; 2007 Jan; 149(1-3):11-23. PubMed ID: 17107716
[TBL] [Abstract][Full Text] [Related]
60. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
Stroup S; Appelbaum P; Swartz M; Patel M; Davis S; Jeste D; Kim S; Keefe R; Manschreck T; McEvoy J; Lieberman J
Schizophr Res; 2005 Dec; 80(1):1-8. PubMed ID: 16182516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
